EUR 14.15
(-0.7%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | 22.31 Million | 17.34 Million | 21.17 Million | 23.71 Million | - |
Net Income | 98.7 Million | 456.77 Million | 3.27 Billion | 661.67 Million | 842.31 Million | 657.6 Million |
Depreciation & Amortization | - | 11.15 Million | 8.67 Million | 10.58 Million | 11.85 Million | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -98.7 Million | -456.77 Million | -3.27 Billion | -661.67 Million | -842.31 Million | -657.6 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | 22.31 Million | 17.34 Million | 21.17 Million | 23.71 Million | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 22.31 Million | 17.34 Million | 21.17 Million | 23.71 Million | - |
Free Cash Flow | - | 22.31 Million | 17.34 Million | 21.17 Million | 23.71 Million | - |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 98.7 Million | 456.77 Million | 3.27 Billion | 661.67 Million | 842.31 Million | 657.6 Million |
Depreciation & Amortization | - | 11.15 Million | 8.67 Million | 10.58 Million | 11.85 Million | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -98.7 Million | -456.77 Million | -3.27 Billion | -661.67 Million | -842.31 Million | -657.6 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | 22.31 Million | 17.34 Million | 21.17 Million | 23.71 Million | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 22.31 Million | 17.34 Million | 21.17 Million | 23.71 Million | - |
Free Cash Flow | - | 22.31 Million | 17.34 Million | 21.17 Million | 23.71 Million | - |
GAL
EBS
NMTP
WLDN
MDSQF
BRW